Rankings
▼
Calendar
IRWD Q4 2023 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
Q4 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$118M
+9.7% YoY
Gross Profit
$118M
100.0% margin
Operating Income
$38M
32.0% margin
Net Income
-$1M
-0.9% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+3.4%
Cash Flow
Operating Cash Flow
$36M
Free Cash Flow
$36M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$471M
Total Liabilities
$817M
Stockholders' Equity
-$346M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$118M
$107M
+9.7%
Gross Profit
$118M
$107M
+10.0%
Operating Income
$38M
$68M
-45.0%
Net Income
-$1M
$49M
-102.2%
Geographic Segments
North America
$432M
100%
← FY 2023
All Quarters
Q1 2024 →